Previous 10 | Next 10 |
2023-03-30 14:07:39 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips While an extremely risky proposition, short-squeeze stocks – as meme traders demonstrated – can occasionally yield radical profitability. However, you don’t want to just pi...
Cutera, Inc. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, announced today that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (...
2023-03-16 17:24:42 ET Gainers: Hub Cyber Security ( HUBC ) +6% . Altimmune ( ALT ) +5% . Hawaiian Holdings ( HA ) +4% . MacroGenics ( MGNX ) +3% . PENN Entertainment ( PENN ) +3% . Losers: Sarepta Therapeutics ( NASDAQ...
Award-winning body sculpting duo introduces a bold new look CUTERA, INC. (Nasdaq: CUTR) a leading provider of aesthetic and dermatology solutions, is proud to reveal the refreshed truBody brand. This award-winning treatment pairs two clinically proven technologies for a customized, conv...
2023-03-07 10:42:35 ET Summary The key negatives for Cutera, Inc. are that its 2023 revenue guidance was below expectations, and the future performance of its aesthetic solutions might be affected by the weak economic environment. Cutera's key positives relate to the strong revenu...
Cutera, Inc. (CUTR) Q4 2022 Earnings Conference Call February 28, 2023 04:30 PM ET Company Participants Dave Mowry - Chief Executive Officer Rohan Seth - Chief Financial Officer Conference Call Participants Jon Block - Stifel Margaret Kaczor - William Blair...
Gainers Lionheart III Corp ( LION ) +23% . Sarepta Therapeutics, Inc. ( SRPT ) +16% . Schrodinger, Inc. ( SDGR ) +12% . Mount Rainier Acquisition Corp. ( RNER ) +11% . eHealth, Inc. ( EHTH ) +9% . Losers: Novavax, Inc. ( NVAX )...
Cutera press release ( NASDAQ: CUTR ): Q4 GAAP EPS of -$0.40 misses by $0.02 . Revenue of $67.4M (+2.7% Y/Y) misses by $2.12M . Full-year 2023 revenue outlook of $277 million to $292 million. The consensus estimate is $305M. For further details see: Cuter...
Full-year 2022 revenue of $252.4 million, growing 16% in constant currency Placed greater than 600 AviClear devices during 2022, and generated $4.5M in AviClear revenue in 2022 Full-year 2023 revenue outlook of $277 million to $292 million, implying 10% to 16% constant currency gr...
Cutera, Inc. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the fourth quarter and full year of 2022 after the market close on Tuesday, February 28, 2...
News, Short Squeeze, Breakout and More Instantly...
CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, and its Japanese subsidiary, Cutera KK, are pleased to announce a strategic partnership with L’Oréal Japan Co. to exclusively promote, market, sell and distribute select SkinCeuticals products to m...
CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced today that it will report financial results for the second quarter ended June 30, 2024, after the market closes on Thursday, August 8, 2024. The Company’s management will host a conference...
New insights reveal the profound impact of acne and the growing interest in modern treatments Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announces the release of important new acne survey data as part of June’s Acne Awareness Month. Th...